Veracyte Announces Eight Decipher-Focused Studies to Be Presented at ASTRO 2026

Six oral presentations and two posters will highlight Decipher’s prognostic and predictive value in identifying patients’ risk of progression and likelihood of benefiting from treatment intensificationSOUTH SAN FRANCISCO, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- Veracyte, Inc. NASDAQ:VCYT, a lead…